Related Experiment Video
Updated: Oct 13, 2025
Generation, Amplification, and Titration of Recombinant Respiratory Syncytial Viruses
Published on: April 4, 2019
New preventive strategies for respiratory syncytial virus infection in children
Rebecca Glowinski1, Asuncion Mejias2, Octavio Ramilo3
1Center for Vaccines & Immunity, Abigail Wexner Research Institute at Nationwide Children's Hospital and The Ohio State University, Columbus, OH, USA.
Insights
Preventing respiratory syncytial virus (RSV) in children is crucial. New monoclonal antibodies and vaccines targeting key RSV proteins offer promising strategies against this common respiratory illness.
Area of Science:
- Virology
- Immunology
- Pediatrics
Background:
- Respiratory syncytial virus (RSV) causes significant illness and death in young children globally.
- Past vaccine development faced challenges, including historical setbacks and limited understanding of immune responses.
- Advances in understanding RSV protein structures have accelerated progress.
Purpose of the Study:
- To review the current landscape of preventive strategies for RSV infections in pediatric populations.
- To highlight the impact of improved knowledge on RSV protein structure for vaccine and antibody development.
- To discuss the potential of emerging monoclonal antibodies and diverse vaccine platforms.
Main Methods:
- Literature review of recent advancements in RSV prevention.
- Analysis of structural biology data for key RSV proteins.
- Evaluation of clinical trial outcomes for new preventive agents.
Main Results:
- Several promising monoclonal antibodies are in late-stage development.
- Novel vaccine platforms targeting RSV are showing encouraging results.
- Improved understanding of viral structure is key to efficacy.
Conclusions:
- New preventive strategies, including monoclonal antibodies and vaccines, are nearing availability for RSV.
- These advancements offer hope for reducing the burden of RSV in young children worldwide.
- Continued research into host immune responses will further refine prevention.
Abstract:
Respiratory syncytial virus (RSV) infections result in significant morbidity and mortality for young children worldwide. The development of preventive strategies for RSV has faced different challenges, including the legacy of the first vaccine attempt, and an incomplete understanding of the host immune response to the virus. However, promising preventive strategies against RSV are in the pipeline and their development has advanced rapidly in the past decade due in part to our improved knowledge about the structural conformation of key RSV proteins. These strategies include monoclonal antibodies and different vaccines platforms directed towards the main target populations.
More Related Videos
09:14An Improved and High Throughput Respiratory Syncytial Virus RSV Micro-neutralization Assay
Published on: January 26, 2019
09:01An In vitro Model to Study Immune Responses of Human Peripheral Blood Mononuclear Cells to Human Respiratory Syncytial Virus Infection
Published on: December 10, 2013
Related Concept Videos
01:30Pneumonia V: Nursing management and Prevention
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
01:25Transmission-based Precautions II: Airborne and Protective Environment
Airborne precautions:
Use airborne precautions when treating patients known or suspected to have diseases that spread through the air—for example, tuberculosis or measles. These organisms are present in smaller droplets expelled by an infected person and...
01:29Acute Respiratory Failure-V
Ensure that patients are monitored continuously for their response to therapy, including changes in...
01:23Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla. Benzonatate operates peripherally within the respiratory tract by...
01:17Drugs Used in Lower Respiratory Disorders: Overview
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
01:31Common Respiratory Disorders
Upper respiratory disorders impact the airways above the vocal cords, encompassing areas like the nose, sinuses, and throat. Various conditions fall under this category, including the common cold and allergic rhinitis. These disorders can stem from several causes,...